Adenomatoid mesothelioma with intranuclear inclusion bodies: A case report with cytological and histological findings

Diagnostic Cytopathology

Volumn 42, Issue 5, 2014, Pages 436-440

  Kawai, Toshiaki ^a   Kawashima, Katsuhiko ^b   Serizawa, Hiromi ^c   Miura, Hiroyuki ^c   Kyeongil, Kim ^d  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Department of Pathology Toda Central Medical Laboratory   (Japan)

^c TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

^d FUKUOKA SANNO HOSPITAL   (Japan)

Author keywords

adenomatoid tumor; cytology; intranuclear inclusions; mesothelioma; pleura

Indexed keywords

ADENOMATOID TUMOR; ADULT; ARTICLE; CANCER CYTODIAGNOSIS; CASE REPORT; CELL NUCLEUS INCLUSION BODY; CYTOLOGY; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOLOGY; HUMAN; LUNG RESECTION; MALIGNANT MESOTHELIOMA; MALIGNANT PLEURA EFFUSION; MIDDLE AGED; PRIORITY JOURNAL; THORACOCENTESIS; THORACOSCOPY; CYTODIAGNOSIS; LUNG NEOPLASMS; MESOTHELIOMA; PATHOLOGY; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS;

ADENOMATOID TUMOR; CYTODIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INTRANUCLEAR INCLUSION BODIES; LUNG NEOPLASMS; MESOTHELIOMA; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS;

EID: 84899463358     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.22932     Document Type: Article

References (24)

1. Ministry of Health, Labour and Welfare. Vital Statistics of Japan 2011. Tokyo: Ministry of Health, Labour and Welfare; 2011.
2. Robinson WS, Lake RA,. Advances in Malignant Mesothelioma. N Engl J Med 2005; 353: 1591-1603.
3. Churg A, Roggli V, Galateau-Salle, et al. Mesothelioma. In:, Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC, editors. Pathology and genetics of tumours of the lung, pleura, thymus and heart. The World Organization (WHO) classification of tumours. Lyon: IARC; 2004. p 125-136.
4. Churg A, Cagle PT, Roggli VL,. Diffuse malignant tumors of the serosal membranes. In:, Churg A, Cagle PT, Roggli VL, editors. Tumors of the serosal membranes. AFIP atlas of tumor pathology series 4. Washington, DC: ARP; 2006. p 46.
5. Kamei T, Akita H, Obayashi C, et al. General rule for clinical and pathological record of lung cancer. [In Japanese]. 7th ed. Kanehara; 2010. p 129.
6. Goedhals J, Beukes CA, Cooper S,. Malignant mesothelioma with intracytoplasmic crystalline inclusions. Ultrastruct Pathol 2006; 31: 73-76.
7. Christ ML, Haja J,. Intranuclear cytoplasmic inclusions (invaginations) in thyroid aspirations. Frequency and specificity. Acta Cytol 1979; 23: 327-331.
8. Das DK,. Intranuclear cytoplasmic inclusions in fine-needle aspiration smears of papillary thyroid carcinoma: A study of its morphological forms, association with nuclear grooves, and mode of formation. Diag Cytopathol 2005; 32: 264-268.
9. Arrossi AV, Lin E, Rice D, Moran CA,. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy. Am J Clin Path 2008; 130: 754-764.
10. Umezu H, Kuwata K, Ebe Y, et al. Microcystic variant of localized malignant mesothelioma accompanying an adenomatoid tumor-like lesion. Pathol Int 2002; 52: 416-422.
11. Weissferdt A, Kalhor N, Suster S,. Malignant mesothelioma with prominent adenomatoid features: A clinicopathologic and immunohistochemical study of 10 cases. Ann Diagn Pathol 2011; 15: 25-29.
12. Minato H, Nojima T, Kurose N, et al. Adenomatoid tumor of the pleura. Pathol Int 2011; 59: 567-571.
13. Rege JD, Amarapurkar AD, Phatak AM,. Fine needle aspiration cytology of adenomatoid tumor A case report. Acta Cytol 1999; 43: 495-497.
14. Doglioni C, Tos AP, Laurino L, et al. Calretinin: A novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996; 20: 1037-1046.
15. Husain AN, Colby TV, Ordõñez NG, et al. Guidelines for pathologic diagnosis of malignant mesothelioma. A consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2009; 133: 1317-1331.
16. Chu PG, Weiss LM,. Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohistochemical study of 509 cases. Mod Pathol 2002; 15: 6-10.
17. Ordõñez NG,. The immunohistochemical diagnosis of mesothelioma: A comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003; 27: 1031-1051.
18. Chu AY, Litzky LA, Pasha TL, et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 2005; 18: 105-110.
19. Butnor KJ,. My approach to the diagnosis of mesothelial lesions. J Clin Pathol 2006; 59: 564-574.
20. Beasley MB,. Immunohistochemistry of pulmonary and pleural neoplasia. Arch Pathol Lab Med 2008; 132: 1062-1072.
21. Bedrossian CWM, Weilbaecher DG, Greenberg SD, Bentick DC,. Ultrastructure of human bronchiolo-alveolar carcinoma. Cancer 1975; 36: 1399-1413.
22. Siddaraju N, Viswanathan VK, Saka VK, Basu D, Shanmugham C,. Fine needle aspiration of follicular variant of papillary thyroid carcinoma presenting with pleural effusion: A case report. Acta Cytol 2007; 51: 911-915.
23. Kaneko C, Kato K, Kobayashi TK, Sakamoto H,. Significance of intranuclear cytoplasmic inclusions in malignant pleural effusion. Diagn Cytopathol 2008; 36: 531-533.
24. Cerruto CA, Brun EA, Chang D, Sugarbaker PH,. Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. Arch Pathol Lab Med 2006; 130: 1654-1661.